myLaurel® | $12,000,000 | (Jun 4, 2025)
Matterworks | Undisclosed Amount | (Jun 4, 2025)
Ciroos | $21,000,000 | (Jun 4, 2025)
Certified by Founder
Lodge
Remix Therapeutics
start up
United States
- Watertown, MA, MA
- 04/01/2024
- Unknown
- $60,000,000
Remix launched in 2020 with a vision to transform patient's lives through modulation of RNA processing. Our breakthrough science provides a path to identify small molecules that impact the expression of disease driving mRNAs and proteins. We take on the challenge of addressing drug targets in diseases of high unmet medical need to bring new therapeutic options to patients. Remix has a commitment to demonstrate the highest levels of scientific integrity with urgency because those patients are counting on us to deliver. With an in-house technology platform built from scratch, we have rapidly generated multiple drug discovery programs that are advancing towards the clinic.
- Industry Biotechnology Research
- Website https://www.remixtx.com/
- LinkedIn https://www.linkedin.com/company/remix-therapeutics/about/
FISPAN | $30,000,000 | (Jun 4, 2025)
Volare Solutions | $29,578,562 | (Jun 4, 2025)
Veris AI | $8,500,000 | (Jun 4, 2025)
ProteinQure | $11,000,000 | (Jun 4, 2025)
Dexari | $2,300,000 | (Jun 3, 2025)
Heron Power | $38,000,000 | (Jun 3, 2025)
Trustifi | $25,000,000 | (Jun 3, 2025)
Infleqtion | $100,000,000 | (Jun 3, 2025)
Literal Labs | $6,223,938 | (Jun 3, 2025)